In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-24 of 24 for your search:
Drug:  pentostatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 03017, NIP-03-007, NCT00254163

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 months to 21 years
Sponsor: Other
Protocol IDs: MUDSIB, NCT01188798

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor:
Protocol IDs: MSKCC-93013, NCI-V93-0268

4.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID00-132, NCT00506922

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 05-077, MSKCC-05077, NCT00546377

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: EORTC-06911, NCI-T91-0028A, T91-0028

7.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: ECOG-E1902, NCT00045305, E1902

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000341678, U10CA031946, CALGB-100101, ECOG-1010, NCT00074035

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Other
Protocol IDs: DM94-026, NCT00038025

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-MC0183, NCT00201721

11.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 10 and over
Sponsor: NCI, NHLBI
Protocol IDs: 285, BMT CTN 0302, U01 HL069294-05, JHOC-05040403, JHOC-J0519, NCT00224874

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: MCC-15009, NCT00496340

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2004-0818, NCT00496873

14.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 05-051, P30CA008748, MSKCC-05051, MSKCC IRB 05-051, NCT00541034

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 19 to 75
Sponsor: Other
Protocol IDs: 389-00, IRB389-00, NCT00571662

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000582676, P30CA015083, MC0784, 07-002156, RV-CLL-PI-146, NCI-2009-01281, MAYO-MC0784, MAYO-07-002156, HOSPIRA-MC0784, NCT00602836

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: LS0881, 08-000673, MAYO-LS0881, NCT00669318

18.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: Under 21
Sponsor: Other
Protocol IDs: 045-2004, NCT00228826

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000630491, P30CA015083, RC0783, 08-002080, AVF4491s, NCI-2009-01225, MCCRC-RC0783, MCCRC-08-002080, NCT00816595

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000258096, CBRG-NIP-0201, NCI-V02-1712, SUPEREN-CBRG-NIP-0201, NCT00049413

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC0983, NCI-2009-01437, OFT113301, 09-003675, NCT01024010

22.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 100025, 10-C-0025, NCT01059786

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 65 and over
Sponsor: Other
Protocol IDs: PCO, 2010-022332-37, NCT01681563

24.

Phase: Phase I
Type: Treatment
Status: Closed
Age: under 26
Sponsor:
Protocol IDs: NCI-80-C-98, NCI-POB-8002
New Search